Listed

Angiodynamics Inc: Form 10-Q for the period ended Nov 30, 2011

Filed with the SEC on Jan 5, 2012 and accepted by EDGAR at Jan 5, 2012, 16:31 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2011-11-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2011-09-01 to 2011-11-30$58.1mus-gaap:SalesRevenueNet
Revenue6 months2011-06-01 to 2011-11-30$112.5mus-gaap:SalesRevenueNet
Cost of revenue3 months2011-09-01 to 2011-11-30$24.9mus-gaap:CostOfGoodsSold
Cost of revenue6 months2011-06-01 to 2011-11-30$47.2mus-gaap:CostOfGoodsSold
Gross profit3 months2011-09-01 to 2011-11-30$33.2mus-gaap:GrossProfit
Gross profit6 months2011-06-01 to 2011-11-30$65.4mus-gaap:GrossProfit
Research and development3 months2011-09-01 to 2011-11-30$5.1mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2011-06-01 to 2011-11-30$10.7mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2011-09-01 to 2011-11-30$3.9mus-gaap:OperatingIncomeLoss
Operating income6 months2011-06-01 to 2011-11-30$6.6mus-gaap:OperatingIncomeLoss
Interest expense3 months2011-09-01 to 2011-11-30$111.0kus-gaap:InterestExpense
Interest expense6 months2011-06-01 to 2011-11-30$227.0kus-gaap:InterestExpense
Income tax3 months2011-09-01 to 2011-11-30$1.2mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2011-06-01 to 2011-11-30$2.0mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2011-09-01 to 2011-11-30$2.3mus-gaap:NetIncomeLoss
Net income6 months2011-06-01 to 2011-11-30$3.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2011-09-01 to 2011-11-30$0.09us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2011-06-01 to 2011-11-30$0.15us-gaap:EarningsPerShareDiluted
Basic EPS3 months2011-09-01 to 2011-11-30$0.09us-gaap:EarningsPerShareBasic
Basic EPS6 months2011-06-01 to 2011-11-30$0.15us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2011-09-01 to 2011-11-3025,340,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2011-06-01 to 2011-11-3025,278,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2011-06-01 to 2011-11-30$5.7mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2011-06-01 to 2011-11-30$1.1mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2011-11-30$43.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2011-11-30$205.8mus-gaap:AssetsCurrent
Total assetsAt period end2011-11-30$443.6mus-gaap:Assets
Current liabilitiesAt period end2011-11-30$26.6mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2011-11-30$32.7mus-gaap:Liabilities
Long-term debtAt period end2011-11-30$6.1mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2011-11-30$290.0kus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2011-11-30$410.8mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-12-003595. Last ingested by Listed: Nov 4, 2026, 20:24 ET. Listed shows no prices and gives no investment advice.